Sickle cell disease trials recruiting in Missouri

All Sickle cell disease trials nationally

Cities in Missouri

Recruiting trials in Missouri

• A Long-term Follow-up Study in Patients Who Received BEAM-101
  NCT07373639 · Phase: Not specified · Ages: 14 Years to 37 Years · Sex: All (male and female) · Missouri: St Louis
• A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
  NCT05431088 · Phase: Phase 2, Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · Missouri: Kansas City
• A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
  NCT06609226 · Phase: Phase 3 · Ages: 2 Years and older · Sex: All (male and female) · Missouri: St Louis
• A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
  NCT06481306 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Missouri: St Louis
• A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
  NCT06612268 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · Missouri: St Louis
• ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
  NCT04398628 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Missouri: Kansas City, St Louis
• Cerebral Oxygen Metabolism in Children
  NCT04157179 · Phase: Not applicable (e.g. observational or device study) · Ages: 3 Years to 50 Years · Sex: All (male and female) · Missouri: St Louis
• Cerebrovascular Reactivity Measurements With High-Density Diffuse Optical Tomography
  NCT07776444 · Phase: Not applicable (e.g. observational or device study) · Ages: 6 Years to 70 Years · Sex: All (male and female) · Missouri: St Louis
• Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
  NCT06941389 · Phase: Not specified · Ages: 3 Years to 20 Years · Sex: All (male and female) · Missouri: St Louis
• Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease
  NCT06919224 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Missouri: St Louis
• Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease
  NCT04819841 · Phase: Phase 1, Phase 2 · Ages: 12 Years to 50 Years · Sex: All (male and female) · Missouri: St Louis
• Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy
  NCT06689800 · Phase: Not applicable (e.g. observational or device study) · Ages: 8 Years and older · Sex: All (male and female) · Missouri: St Louis
• Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
  NCT03128996 · Phase: Phase 1, Phase 2 · Ages: 1 Day to 21 Years · Sex: All (male and female) · Missouri: St Louis
• Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
  NCT06699849 · Phase: Phase 2 · Ages: 12 Years and older · Sex: All (male and female) · Missouri: St Louis